| 李林均 余建云 许涛 张军 程雄飞 焦娇 曹凤军 姜孝新.不同临床分期肝癌患者抗AFP Th1 和Tc1 应答反应研究[J].,2015,15(18):3506-3509 |
| 不同临床分期肝癌患者抗AFP Th1 和Tc1 应答反应研究 |
| 不同临床分期肝癌患者抗AFP Th1 和Tc1 应答反应研究 |
| |
| DOI： |
| 中文关键词: 甲胎蛋白（AFP） 肝细胞癌（HCC） 疾病分期 Okuda Child-Pugh |
| 英文关键词: Alpha-fetoprotein (AFP) Hepatocellular carcinoma (HCC) Stage of disease Okuda Child - Pugh |
| 基金项目:湖南省自然科学基金项目（14JJ2092） |
|
| 摘要点击次数: 644 |
| 全文下载次数: 801 |
| 中文摘要: |
| 目的：研究CD4（Th1）和CD8（Tc1）T 细胞对肝癌患者的AFP的应答反应及其与临床特征的相关性，为其早期诊断与预防提
供新策略。方法：研究对象为62 例HCC患者，30 例肝硬化患者及30 例健康志愿者；重点分析CD4 T 细胞和CD8 T细胞对HCC
患者的AFP- 衍生肽的反应；用胞内细胞因子检测法对IFN-gamma进行检测。结果：抗AFP 的Tc1 反应检测阳性结果在对照组为
28.5%，在OkudaⅠ期的肝癌患者中为25.0％，在Ⅱ 或Ⅲ 期的HCC 患者中为31.6%。抗AFP Th1 阳性反应仅在HCC 患者中检测
到。抗AFP Th1 阳性反应在44.4%的Child-Pugh A级的HCC 患者中检测到，但是在Child-Pugh B或C级中仅15.4%。Tc1 型反应
在Child-Pugh A级肝功的患者中为16.7%，在Child-Pugh B或C级患者中为46.2%。结论：抗AFP Th1应答更多出现在早期肝硬
化的HCC 的患者中，而抗AFP Tc1 应答更可能出现在晚期肝硬化患者中，这些结论为抗肝癌疫苗药物设计提供了理论基础。 |
| 英文摘要: |
| Objective:Alpha-Fetoprotein (AFP) is a kind of tumor associated antigen in hepatocellular carcinoma (HCC), and it is
also the target of immune therapy. However, there is little information on the pattern of CD4 (Th1) and CD8 (Tc1) T-cell response to
AFP in patients with HCC or on their association with clinical characteristic of patients. Therefore, we observed the CD4 (Th1) and CD8
(Tc1) response of T cells in patients with hepatocellular carcinoma AFP and its clinical features.Methods:The subjects were 62 Patients
with HCC, 30 patients with liver cirrhosis and 30 healthy people as control. CD4 and CD8T-cell responses to AFP-derived peptides of 62
HCC patients were studied, and intracellular cytokine method was applied to detect IFN- gamma.Results:The rate of positive results of Tc1
reaction of anti AFP was 28.5%in the control group, 25.0% in patients with hepatocellular carcinoma in OkudaⅠ, and in phaseⅡor III
of HCC patients was 31.6%. Anti AFP Th1 positive reaction was detected only in HCC patients. 44.4%of HCC patients with Child-Pugh
A were Th1 reaction; however, this was detected in only 15.4% with B or C score. Tc1 reaction was detected in 16.7% of patients with
Child-Pugh A and Child-Pugh B or C level was 46.2%.Conclusion:The results show that anti-AFP Th1 reactions mainly occurred in
patients with disease in early stage, anti AFP Tc1 responses are more likely to occur in patients with late stage cirrhosis, therefore, these
data provide effective information for vaccine design against hepatocellular carcinoma. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
